Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)
- 19 December 2023
- journal article
- research article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 65, 152347
Abstract
No abstract availableKeywords
Funding Information
- Medical College, Weill Cornell Medicine
This publication has 22 references indexed in Scilit:
- Cessation of oral anticoagulants in antiphospholipid syndromeLupus, 2017
- Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management studyBMJ, 2017
- The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndromeExpert Review of Clinical Immunology, 2015
- Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patientsAnnals of the Rheumatic Diseases, 2015
- APS ACTION – AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal NetworkingLupus, 2012
- Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary EmbolismCirculation, 2010
- Clinical course of high‐risk patients diagnosed with antiphospholipid syndromeJournal of Thrombosis and Haemostasis, 2010
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patientsJournal of Thrombosis and Haemostasis, 2009
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)Journal of Thrombosis and Haemostasis, 2006
- Importance of events per independent variable in proportional hazards analysis I. Background, goals, and general strategyJournal of Clinical Epidemiology, 1995